Anson Funds Management LP Cytosorbents Corp Transaction History

Anson Funds Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.88 - $4.23 $492,474 - $723,321	-170,998 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $692,541 - $1.39 Million	170,998 New	170,998 $716,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $280,638 - $575,421	-74,440 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $268,728 - $388,576	74,440 New	74,440 $287,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.